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ABSTRACT 
 
Coccidiosis is an intestinal parasitic disease caused by protozoans of the genus Eimeria and 
substantially impacts the poultry industry economically worldwide by diminishing animal 
growth. The prophylactic use of anticoccidial drugs in order to ameliorate the detrimental effects 
of an Eimeria infection has been the most successful control measure in broilers. However, due 
to an increase in resistance to anticoccidial drugs and a growing public concern for the 
development of resistant microorganisms, dietary intervention as a nutritional alternative to 
antibiotics and anticoccidial drugs have become of specific interest to combat coccidiosis in 
broilers. Because of this, an experiment was conducted to determine if dietary Yucca-derived 
saponin supplementation could mitigate the immune and growth responses of broilers during a 
mixed coccidian challenge. Dietary treatments were corn-soybean meal-based and included: 1) 
control diet + sham-inoculated (Ucon), 2) control diet + Eimeria oocyst challenge (Icon), 3) 
control diet with 250 mg/kg Yucca-derived saponin product + Eimeria oocyst challenge 
(ISap250), and 4) control diet with 500 mg/kg of Yucca-derived saponin product + Eimeria 
oocyst challenge (ISap500). Growth performance, oocyst shedding, histopathological 
morphometrics and lesion scoring, differential blood cell counts, immunophenotyping of cecal-
derived T-cell profiles, and intestinal inflammatory cytokine gene expression were evaluated in 
broilers inoculated with a mixture of E. acervulina, E. maxima, and E. tenella oocysts. The birds 
challenged with Eimeria showed clear signs of a successful infection, as evidenced by oocyst 
counts of excreta samples collected from each pen. The birds challenged orally with the Eimeria 
mixture displayed a reduction in growth compared with birds not challenged with the Eimeria 
mixture, but there was no detectable difference due to dietary treatment when comparing 
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amongst infected birds alone. Histopathological analysis identified a treatment effect for mucosal 
thickness in the jejunum, where infected birds fed an inclusion rate of 250 mg/kg of diet of 
saponin supplementation and the un-infected control diet birds were not significantly different 
from each other. Histopathological lesion scoring exhibited no detectable differences due to 
dietary treatment within the Eimeria-infected groups. Seven days following Eimeria inoculation, 
lymphocytes as a percentage of white blood cells were elevated in all infected treatment groups, 
but birds fed saponin supplementation at 250 mg/kg of diet did not differ from the un-infected 
control diet birds. Saponin supplementation in conjunction with an Eimeria challenge had no 
measureable effect on cecal-derived T-cell profiles. Expression of cecal and duodenal IFN-γ 
increased with infection when compared to the sham-inoculated birds. Inoculation with Eimeria 
also increased expression of IL-1β, but saponin supplementation at 250 mg/kg and 500 mg/kg of 
diet ameliorated IL-1β expression in the cecal tonsils and duodenum to levels not different from 
sham-inoculated birds. Overall, this research demonstrates that dietary intervention in the form 
of saponin supplementation may serve as an effective strategy in mitigating the resulting 
inflammatory response following exposure to Eimeria in broilers as evidenced by lymphocyte 
responses, changes in intestinal structure, and alterations in cecal and duodenal inflammatory 
cytokine mRNA expression. 
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CHAPTER 1: INTRODUCTION 
  
 Coccidiosis is a major parasitic disease affecting the poultry industry and causes severe 
economic loss worldwide of more than $3 billion USD (Dalloul & Lillehoj, 2006; Williams, 
1999). The disease is caused by a protozoan in the genus Eimeria, an intracellular parasite whose 
predilection site is along the gastrointestinal tract (GIT) of broiler chickens (McDougald & Fitz-
Coy, 2008). Coccidiosis is manifested by a destruction of the intestinal epithelia and elicits an 
immune response within the host, thereby leading to increased maintenance costs, decreased 
absorption of nutrients, and ultimately causes diminished animal growth (Turk & Stephens, 
1967). Because of the pathogenicity of Eimeria species and current management practices within 
the poultry industry, a variety of control measures have been developed to mitigate the 
detrimental effects of coccidiosis. The most successful of these measures being prophylactic 
chemotherapeutic agents or anticoccidial drugs (Dalloul & Lillehoj, 2006), in addition to the use 
of vaccination programs (Chapman, 2014). Importantly, a shift in Eimeria susceptibility to 
anticoccidial drugs was noted soon after discovery of the drugs, and evidence of global coccidial 
resistance to chemotherapeutic agents has been demonstrated for almost all anticoccidial drugs 
(Abbas et al., 2011). Public concern regarding the resistance of microorganisms to control 
strategies (Cosby et al., 2015; Endtz et al., 1990) and implications in human health have been 
increasing over the past decade. The affirmation that science and technology will continuously 
create novel, more efficient drugs to counteract microorganismal resistance has dwindled (Gold 
& Moellering, 1996). As the industry heads towards an antibiotic-free era brought on by pressure 
from both consumers and regulatory agencies, dietary intervention and the discovery of 
alternatives for antibiotics and anticoccidial drugs without detriments in growth performance has 
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become of upmost importance to the poultry industry. A plethora of alternatives have been 
introduced to the poultry industry, all of which seek to maintain optimal growth performance 
while promoting overall bird health (Gadde et al., 2017). Phytogenic compounds are non-
antibiotic feed additives of plant origin and are available as solids, extracts, and essential oils 
(Yitbarek, 2015). Saponins are one type of phytogenic compounds that have been suggested as 
an alternative to anticoccidial drugs due to their antiprotozoal activity (Cheeke, 2000). Saponins 
are natural detergents that consist of a lipophilic nucleus, either steroid or triterpenoid in 
structure depending on plant origin, with one or more water-soluble carbohydrate side chains 
(Cheeke, 2000; Francis et al., 2002). Saponins have the ability to bind to membrane cholesterol 
of protozoan cells, thus creating saponin-cholesterol complexes that can modify membrane 
function and structure, leading to eventual cell lysis and cell death (Francis et al., 2002). 
Saponins also have the ability to improve nutrient digestibility (Johnson et al., 1986), growth 
performance (Sahoo et al., 2015; Sun et al., 2017), and odor control (Çabuk et al., 2004). 
Phytogenic compounds, specifically saponins, may prove to be an effective alternative to 
antibiotics and anticoccidial drugs due to their antiprotozoal activity and ability to enhance 
nutrient absorption and growth of broilers. These products offer a natural alternative to 
prophylactic chemotherapeutic agents in addition to staying in the realm of governmental 
regulations while assuaging to the growing public concern for microorganismal resistance. 
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CHAPTER 2: LITERATURE REVIEW 
Coccidiosis in Poultry 
Introduction and Impact 
 Parasitic infections cause severe economic damage to the poultry industry and can be 
attributed to two general groups, coccidia and mastiogophora (McDougald, 1998). Infection from 
the more common coccidia results in coccidiosis, which continuously and substantially affects 
the cost of poultry production. Globally, coccidiosis causes a severe economic impact by costing 
producers up to $3 billion USD in annual losses (Dalloul & Lillehoj, 2006; Williams, 1999). 
 The prevalence of coccidiosis in today’s flocks is not a new problem afflicting the poultry 
industry. Walter T. Johnson first published on avian coccidiosis (Johnson, 1923) over 95 years 
ago. Today, it is rare to find a poultry flock that has not been infected or exposed to coccidia, 
which can be found wherever chickens are raised (Mcdougald et al., 1986; Williams, 1998). Due 
to subclinical exposure and a depletion in traditional rearing space (near 15 birds/m2), birds are 
ingesting and shedding coccidian oocysts in a confined area making it easy for birds raised on 
litter to be continually re-exposed to active coccidia oocysts. Exposure to large quantities of 
oocysts have the potential to overwhelm the avian immune system, and activate an immune 
response within the birds (H.S. Lillehoj & Lillehoj, 2000; Williams, 2001). These exposure 
patterns, coupled with the rise in anticoccidial drug resistance due to extensive use (Sundar et al., 
2017), have lead producers to seek other means of action to control and combat coccidiosis.  
 Coccidiosis is caused by a protozoan parasite that belongs to the genus Eimeria. Within 
the genus Eimeria, seven different species are widely encountered within the poultry industry, all 
of which are intracellular parasites that rely on both external (environment) and internal (host 
animal) developmental stages (H.S. Lillehoj & Lillehoj, 2000). These include E. tenella, E. 
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acervulina, E. maxima, E. brunetti, E. mitis, E. praecox, and E. necatrix (McDougald, 1998). Of 
the seven species, all are pathogenic, but only E. acervulina, E. brunetti, E. maxima, E. necatrix, 
and E. tenella yield quantifiable gross lesions in varying spots along the gastrointestinal tract and 
their severity ranges from moderate-to-severe, respectively (Allen & Fetterer, 2002). Mortality 
due to a coccidian infection is rare, but has been reported during infection with E. tenella at a 
dose of 1 × 104 or more sporulated oocysts, making it the most pathogenic species found in 
chickens (McDougald & Fitz-Coy, 2008). 
 The preferred site of habitation varies by Eimeria species along the gastrointestinal tract 
(GIT) of broiler chickens. Eimeria acervulina targets the duodenum, E. maxima the ileum, and 
E. tenella inhabits the ceca (McDougald & Fitz-Coy, 2008). Subjectively viewing gross lesions 
along the intestines of birds enables producers to identify which species of coccidia may be 
infecting their flock, which can aid in controlling the disease. Coccidiosis is manifested by a 
destruction of the intestinal epithelia, thereby leading to increased maintenance costs for tissue 
repair and decreased absorption of nutrients (Turk & Stephens, 1967). Weight loss and poor feed 
conversion have been attributed to both anorexia and other general factors, such as 
malabsorption (Russell & Ruff, 1978). Anorexia induced by an Eimeria challenge accounted for 
30-70% of the suppression in body weight gain, while the remainder was accredited to a 
disruption in nutrient absorption as determined in pair-wise feeding studies (Preston-Mafham & 
Sykes, 1970). 
Pathogenesis  
Coccidia are unique in that they are self-limiting and must undergo a continual cycling 
both inside and outside of a host (McDougald & Fitz-Coy, 2008). Infection begins with ingestion 
of sporulated oocysts, which can be derived from contaminated litter, feed, or water. An oocyst 
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remains inert until it becomes sporulated in the environment, and sporulation occurs when 
adequate levels of moisture, oxygen, and heat are attained, typically over a 24-48–hour period 
(Austic & Nesheim, 1990). These three characteristics, oxygen, moisture, and heat, are also 
crucial variables regulated in commercialized poultry facilities, making it the ideal environment 
for oocysts to sporulate and thrive. Once sporulated, oocysts remain viable for an extended 
period, with E. acervulina oocysts found to be infective for up to 86 weeks after being extracted 
from excreta and placed on outdoor soil plots (Farr & Wehr, 1949; Fayer, 1980). After ingestion 
of sporulated oocysts, they are degraded in the gizzard to expose sporocysts (McDougald, 1998). 
These sporocysts come in to contact with bile and trypsin found in the small intestine causing a 
release of sporozoites that invade enterocytes along the GIT. Once embedded in the epithelia 
lining of the GIT, sporozoites undergo schizogony, a process of growth and division 
accumulating hundreds of daughter cells called merozoites. After two or three generations of 
schizogony, merozoites have two fates, spreading to invade additional host cells or forming 
either microgametes or macrogametes. Macrogametes are fertilized by the released motile 
microgametes in a sexual fission to form a zygote, which undergo maturation to form a new 
oocyst that is excreted into the environment (Austic & Nesheim, 1990; McDougald, 1998).  
Each Eimeria species undergoes a life cycle similar to that described above, but the 
timing and reproductive potential varies depending on oocyst pathogenicity. For more 
pathogenic species, like E. tenella, the potential to reproduce is lowered, whereas, less 
pathogenic species, like E. acervulina, exhibit higher potentials to reproduce (McDougald, 
1998). The process from initial oocyst infection to final zygote excretion generally takes 4 to 5 
days, with maximum oocyst shedding occurring 6-to-9 days after initial infection (Allen & 
Fetterer, 2002). Considering the cyclic reproductive cycle of Eimeria and scale of the broiler 
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industry, one infected bird can shed thousands of new oocysts and initiate an exponential spread 
of oocysts in a very short time, making avoidance of reinfection nearly impossible.  
Invasion of Eimeria in the host causes an array of metabolic, physiologic, and 
immunologic issues. At the tissue level, Eimeria destroys enterocytes and degrades the protective 
mucosal lining of the GIT, which reduces nutrient absorptive capacity, induces ulceration, 
predisposes birds to pathogenic bacteria, elicits an immune response, and in severe cases, results 
in internal bleeding (Austic & Nesheim, 1990). Ulceration and destruction of mucous 
membranes reduces the primary physical barrier to subsequent infection by bacteria such as 
Clostridium perfringens, a major predisposing factor of necrotic enteritis (Van Immerseel et al., 
2004). In severe cases, a coccidian infection has the ability to invade and destroy enterocytes at 
the tips of villi, thereby leaving a barren GIT with severely reduced absorptive capacity 
(McDougald & Fitz-Coy, 2008). Intestinal lesions can physically be seen along the GIT of a bird 
that has been infected with coccidiosis. Severity of the lesions depends largely on the Eimeria 
species, oocyst load, age of the bird, and the original immune state of the bird. Additionally, 
these lesions can be indicative of other parameters induced by infection, such as reduced weight 
gain. Lesion scoring immediately after euthanasia has been reported using a scale of 0-4 where 
0=normal and 4=most severe in addition to histopathological analysis in order to quantify the 
coccidian state to which a bird has been exposed (Johnson & Reid, 1970; McDougald & Fitz-
Coy, 2008). 
As a result of tissue damage, diarrhea and decreased skin and shank pigmentation are 
among some of the clinical signs of coccidiosis infection in a flock. Michael Ruff and Henry 
Fuller (1975) demonstrated that birds orally inoculated with sporulated E. acervulina and E. 
tenella oocysts, 1,000,000 and 100,000, respectively, had notably reduced plasma carotenoids, 
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thus changing the skin and shank pigmentation of infected birds. The most detrimental effect 
economically of coccidiosis in chickens is reduction in weight gain and feed efficiency due to 
depressed feed intake, malabsorption, and diarrhea as a result of subclinical exposure (Williams, 
1999). A meta-analysis conducted by Kipper et al. (2013) compiled data from 69 publications, 
around 44,000 birds, to quantify the variation in feed intake and weight gain across multiple 
species of Eimeria. Their results showed that a variation in feed intake quadratically influenced 
the impairment of weight gain, and the severity of this effect was dependent on many factors 
including, sex, age, Eimeria species, and environmental conditions (Kipper et al., 2013). 
Mortality due to coccidia is rare, making it difficult for a producer to physically see if their flock 
is infected until it is too late and an outbreak has occurred. Thus, it is imperative that farmers 
take preventive measures to reduce the effects of a coccidian infection.  
Control Measures  
 Based on the reproductive cycle of Eimeria species and management practices within the 
poultry industry, a variety of control measures have been developed to mitigate the detrimental 
effects of coccidiosis. The most successful of these measures, by far, is the use of prophylactic 
chemotherapeutic agents, or anticoccidial drugs, which have been deemed as “absolute 
requirements to control the disease” (Dalloul & Lillehoj, 2006). Anticoccidial drugs can be 
classified as chemicals (e.g., amprolium, clopidol decoquinate, halofuginone), which directly 
affect parasite metabolism, or polyether ionophores (e.g., monensin lasalocid, salinomycin, 
narasin), which alter osmotic balance and ion transport of potassium and sodium in the GIT of 
the birds to make the intestinal environment less habitable (Chapman, 2001, 2014; McDougald, 
1998). When an anticoccidial drug is used to directly destroy coccidian populations, they are 
termed coccidiocidal, whereas the prophylactic use of an anticoccidial drug is termed as 
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coccidiostatic (Kant et al., 2013). Determining the criteria to evaluate the efficacy of an 
anticoccidial drug should be based on the objective of the experiment, but most often weight gain 
(global indicator of infection severity), lesion scores (pathology of infection), serum parameters 
(alterations in absorption of infection), and feed intake (anorexic behavior of infection) are 
clinical outcomes taken into consideration (Chapman, 1998).  
Prophylactic use of anticoccidial drugs have proven to be extremely beneficial for 
producers, however, due to the extensive use of these drugs worldwide, coccidia have been able 
to develop a tolerance, thus limiting the effectiveness of anticoccidial drugs (Abbas et al., 2011). 
Grumbles et al. (1948) first reported on the beneficial effects of prophylactic use of an 
anticoccidial drug (sulfaquinonxaline) to control coccidiosis and less than ten years later, 
evidence of resistance was reported by Cuckler et al. (1955). Because of the growing concern for 
the diminishing effectiveness of anticoccidial drugs due to evolved resistance, implementation of 
shuttle or rotation programs have been in heavy use by the broiler industry to prolong the 
benefits of anticoccidial drugs. A shuttle program consists of using two or more drugs, usually 
with different modes of action, whereas a rotation program utilizes different drugs in successive 
flocks (Chapman, 2014). A study of the use of anticoccidial drugs in the U.S. broiler industry 
analyzed data compiled from 1995 to 1999 and concluded that the use of chemical compounds 
may be superior to prophylactic ionophores in reducing resistance to control agents (Chapman, 
2001). 
Anticoccidial drug resistance has forced the industry to seek alternative methods for 
treating coccidiosis, and recent efforts have focused on vaccine development. The use of live 
vaccines takes advantage of the protective immunity a bird develops early on in life, allowing 
vaccinated birds to become immune to species-specific coccidiosis prevalent in the vaccine 
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(Dalloul & Lillehoj, 2006). Coccidian vaccines can either be virulent (non-attenuated), derived 
from laboratory or field strains with their original integrity, or attenuated, with artificially-
reduced virulence, and the difference of these two is reflected in the clinical outcomes of the 
birds. R. B. Williams (2002) compiled literature on broiler growth performance data available for 
commercially-available anticoccidial vaccines (Paracox®, Coccivac®, Immucox®, Livacox®, and 
Nobilis COX ATM®), both attenuated and nonattenuated, in which vaccinated birds did not 
outperform non-vaccinated birds in 32 of the 43 studies . Despite this evidence, there is still a 
push for the use of vaccines over anticoccidial drugs in managing coccidiosis due to other 
benefits, such as animal welfare, absence of drug residuals, and avoidance of toxicity (Williams, 
2002).  
Growth performance loss due to mild Eimeria challenges via a vaccine, may result in a 
decrease in performance. Nevertheless, this may be recovered through compensatory gain, a 
process in which the bird compensates for the loss of growth with a general increase in feed 
consumption and weight gain and is especially apparent in birds taken to a large target weight 
(McDougald & McQuistion, 1980). However, producers cannot always be reliant on 
compensatory gain to ameliorate adverse effects of a coccidiosis vaccination, but it is because of 
this, nutritional intervention during the recovery phase of a transient Eimeria infection has 
become a crucial role in combatting an Eimeria infection in chickens.  
 
The Avian Immune System and Response to Eimeria Infection 
Innate and Adaptive Immune Systems  
 Immunology is a science that defines the way an organism protects and defends itself 
from external and internal danger signals. Protection against pathogens relies on several different 
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levels of defense without exerting unwarranted damage to host cells, while generating 
immunological memory to recognize the same pathogen with higher efficiency in the future. This 
requires recognition, development, regulation, and differentiation processes to act in 
collaboration and ensure a successful immune response to counteract pathogens. These responses 
are coordinated by two major defense mechanisms, the innate and adaptive arms of immunity, 
which work in cooperation to overcome infection (Murphy & Weaver, 2016).  
The innate immune system is comprised of both anatomic barriers, such as the skin, oral 
mucosa, respiratory epithelium, and intestinal lining, and chemical barriers, such as complement 
and secretion of antimicrobial peptides and polymorphonuclear leukocytes. The innate immune 
system is activated immediately following breach of these barriers with a foreign pathogen, 
making its defense mechanisms non-specific, and is mediated by monocyte-derived 
macrophages, granulocytes, natural killer (NK) cells, and serum proteins (Dalloul & Lillehoj, 
2006). Granulocytes include heterophils (i.e., the equivalent of mammalian neutrophils) that 
possess phagocytic capability to engulf and destroy pathogens, in addition to basophils, 
eosinophils, and mast cells, but in smaller proportions compared to heterophils (Schat et al., 
2013). Innate immune cells are outfitted with pattern recognition receptors (PRRs), such as toll-
like receptors, in order to recognize pathogen-associated molecular patterns (PAMPs) or 
damage-associated molecular patterns (DAMPs) (Murphy & Weaver, 2016). Once activated, 
these PRRs then initiate transcription of chemokines and cytokines, small proteins that are 
crucial to an immune response and are triggered for release by bacteria. Chemokines act as 
chemoattractants to stimulate the migration of cells to the site of infection and activate 
phagocytic cells and lymphocytes while cytokines can affect the behavior of other cells (Murphy 
& Weaver, 2016). Detection of a pathogen via PRRs initiates a rapid recruitment of additional 
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innate immune cells that secrete cytokines and chemokines to alter the behavior of surrounding 
cells through signaling, attract additional immune cells to the site of infection, and induce 
inflammation (Murphy & Weaver, 2016). 
Following activation of the innate immune response, development of the adaptive 
antigen-specific memory immune response is reciprocated. This process can be mediated either 
humorally by B-lymphocytes (B-cells) or cellularly by T-lymphocytes (T-cells) (H.S. Lillehoj & 
Lillehoj, 2000). T-cell generation occurs in the thymus where subsets can gain functional identity 
by differentiating into either CD4+CD8- or CD4-CD8+ T-cells, whereas B-cell generation takes 
place in the bursa of Fabricius (Dalloul & Lillehoj, 2006). After differentiation in their respective 
primary lymphoid organ, B and T cells migrate to secondary lymphoid tissues like the spleen, 
lymph nodes, gut-associated lymphoid tissue (GALT), or mucosal-associated lymphoid tissue 
(MALT) (Dalloul & Lillehoj, 2006). Secondary lymphoid tissue acts as a hub for lymphocytes to 
congregate and await activation via antigen presentation cells, which stimulate the lymphocytes 
to differentiate even further into their effector cells.  
Antigen-presenting cells, like macrophages and dendritic cells, form the bridge between 
innate and adaptive immunity because they are able to detect, process, and present an antigen to 
lymphocytes (Murphy & Weaver, 2016). They reside in healthy peripheral tissues and migrate 
from the site of infection after detection of PAMPs or DAMPs to secondary lymphoid tissue via 
lymphatics to activate naïve lymphocytes that are then deployed to the site of infection. Mature 
CD4+CD8- (CD4) are known as helper T-cells and recognize antigens presented by major 
histocompatibility complex (MHC) class II molecules on the cell membranes of macrophages 
and dendritic cells and then signal to the cell to become activated (Murphy & Weaver, 2016). 
Likewise, mature CD4-CD8+ (CD8) are known as cytotoxic T-cells and recognize antigens 
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presented by MHC class I molecules and directly kill the infected cell. For B cell activation, B-
cell receptors on the cell membrane bind to antigens or peptides derived from endocytosed 
antigens presented on the cell membrane in affiliation with MHC class II molecules. Helper T-
cells also recognize these MHC class II molecules, bind to the B-cell, and then aid in binding 
CD40 (on B-cell) to CD40L (on helper T-cell). B-cell receptor bonding to antigens coupled with 
CD40 binding to CD40L activates the naïve B-cell to promote immunological memory, cytokine 
production by macrophages and dendritic cells, and immunoglobulin secretion (Schat et al., 
2013). 
Macrophages possess phagocytic and cytotoxic activity to clear pathogens as well as 
secrete cytokines, such as interleukin-1β (IL-1β) and interleukin-12 (IL-12), in order to initiate an 
immune response (Murphy & Weaver, 2016). The pro-inflammatory cytokine, IL-1β, is 
introduced into peripheral circulation by activated macrophages and elicits systemic metabolic, 
behavioral, and cellular changes (Klasing & Leshchinsky, 1999). Injection of recombinant rat IL-
1β was comparable in strength to administration of lipopolysaccharide when comparing 
reductions in body weight due to sickness-like behaviors (Dantzer et al., 1993). Secreted IL-12, 
or NK-cell stimulatory factor, activates NK cells, which are important in protecting the host from 
pathogens because they have the ability to induce cell lysis and secrete the cytokine interferon-
gamma (IFN-γ) (Murphy & Weaver, 2016). In turn, IFN-γ increases the expression of MHC 
class II antigens and activates lymphocytes and macrophages, thus serving as a mediator of 
acquired immunity (H.S. Lillehoj & Lillehoj, 2000). Interferon- γ is crucial in the control of 
infections induced by intracellular pathogens (Schat et al., 2013), like Eimeria, in addition to 
other parameters that will be detailed below. 
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Immune Response to Eimeria Infection 
 The immunogenicity of Eimeria is dependent on species, making protective immunity, 
once attained for a specific strain, extremely specific and long lasting, but offers little help in 
protection against other species of Eimeria (Yun & Lillehoj, 2000). Although immunity is 
species-specific, the chicken’s immune system exerts three inhibitory effects during three stages 
of the life cycle found in all Eimeria species. First, the avian immune system is able to detect an 
infection of parasites and works to inhibit invasion of intestinal epithelial cells (Jeurissen et al., 
1996). Second, it inhibits the interaction of parasites with intraepithelial lymphocytes embedded 
in the GIT. And lastly, it disassociates penetration of the lamina propria (Jeurissen et al., 1996). 
This suggests that chickens are not able to inhibit an invasion, but rather inhibit development of 
Eimeria. Susceptibility to Eimeria is heightened in young chicks (i.e., less than 14 days post-
hatch) lacking immunocompetence and this is especially pertinent for E. maxima, which is able 
to cause infection with a relatively small number of oocysts compared with other Eimeria species 
(Dalloul & Lillehoj, 2006; Yun & Lillehoj, 2000).  
 Due to its enteric nature, the majority of an Eimeria-induced immune response is 
compartmentalized to the GALT, including the intestinal mucosal layer, bursa of Fabricius, 
aggregates in the urodeum and proctodeum, Peyer’s patches, and cecal tonsils (Befus et al., 
1980). The GALT has three main functions during an enteric infection: process and present 
antigens, produce intestinal antibodies, such as IgA, and activate cell-mediated immunity 
(Dalloul & Lillehoj, 2005). Evidence suggests cell-mediation is the major factor driving an 
adaptive immune response during an Eimeria infection in broilers (Allen & Fetterer, 2002; Yun 
& Lillehoj, 2000). Further evidence solidifies this theory when bursectomized chicks were still 
able to develop protective immunity against coccidiosis, revealing that a cellular-mediated 
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response was likely the driving force for acquired immunity to Eimeria while the humoral 
immune response plays only a minor role (Long & Pierce, 1963). A cell-mediated response is 
characterized by antigen specific and non-specific activation to stimulate diverse cell populations 
including NK cells, macrophages, and T lymphocytes, with the latter two accounting for the 
majority of intestinal leukocytes during an Eimeria infection (Lillehoj & Trout, 1996; Vervelde 
et al., 1996).  
 The cell-mediated response to an Eimeria infection is demonstrated by secretion of 
various cytokines, and T helper cells differentiate based on the profile of cytokines they secrete. 
The dichotomy of helper T cells has not fully been established within chickens, but type I helper 
cells (TH1) govern phagocyte-dependent protective responses, and activate macrophages, in 
addition to secretion of pro-inflammatory cytokines like IFN-γ, interleukin-2 (IL-2), and tumor 
necrosis factor-α (TNF-α) (Romagnani, 1999; Erf, 2004). In contrast, type II helper cells (TH2) 
are responsible for phagocyte-independent protective responses and inhibition of macrophages, 
in addition to secretion of anti-inflammatory cytokines like interleukin-10 (IL-10), and 
interleukin-13 (IL-13), thus acting as a regulator of an immune response (Romagnani, 1999; Erf, 
2004). Evidence suggests that TH1 immune responses are dominant over TH2 immune responses 
during an Eimeria infection. The primary cytokine secreted during a TH1 response is IFN-γ, and 
is one of the immunological parameters that is indispensable for host protection from Eimeria in 
addition to lymphocytes (Chapman et al., 2013). Birds subjected to an E. acervulina challenge 
exhibited local expression of IFN-γ mRNA in the intestine (Choi et al., 1999). Splenic 
lymphocytes isolated from Eimeria-challenged birds also exhibited an elevated concentration of 
IFN-γ protein consequent to ex vivo mitogen stimulation (Martin et al., 1994). When birds were 
infected with E. acervulina and treated with injections of chicken-IFN-γ, birds that received 
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chicken-IFN-γ treatment lost less weight and recovered more quickly (Lowenthal et al., 1997). 
These studies demonstrate the reliance of IFN-γ-producing TH1 cells during Eimeria challenges 
and further attest to cell-mediated immune responses being the driving force for combatting an 
Eimeria infection.  
 Cytokines and chemokines also play a crucial role during the immune response to an 
Eimeria infection. Secretion of TNF-α, a pro-inflammatory cytokine, from splenic macrophages 
was significantly increased 3-6 days after Eimeria inoculation (Byrnes et al., 1993). Expression 
of IL-2, a potent growth factor cytokine for T-cell proliferation, was increased in spleen 
lymphoblasts following primary and secondary infections with E. acervulina. This increase in 
expression of IL-2 coincided with an increase in splenic γδ T-cells, suggesting favorable growth 
of T-cells via increased production of IL-2 following secondary infection with Eimeria (Choi & 
Lillehoj, 2000). Seven days following an E. tenella infection, RNA was isolated from cecal 
tissue and the chemokines K203 and macrophage inflammatory factor 1β were upregulated by 
200-fold and 80-fold, respectively (Laurent et al., 2001).  
An acute phase response (APR) is a non-specific innate immune response and is integral 
in early-defense against pathogens (Cray et al., 2009). An APR causes systemic disturbances in 
homeostasis such as anorexia, fever, and cytokine production, but most importantly, are the 
changes in plasma proteins called acute-phase proteins (APP) (Schat et al., 2013). Any protein 
whose plasma concentration is altered by 25% or more succeeding an inflammatory stimuli is 
classified as an APP and host defense APPs include C-reactive protein, mannan-binding lectin, 
and fibrinogen (Schat et al., 2013). Following an infection with Eimeria, acute-phase proteins in 
the serum were found to be altered using a proteomics approach (Gilbert et al., 2011). Georgieva 
et al. (2010) also saw a significant increase in APPs (fibrinogen and ceruloplasmin) following 
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inoculation with E. tenella. The relevance of APPs during an Eimeria infection may not be well 
understood, but stimulation of increased levels of APPs is evident and further research to 
pinpoint their role during an Eimeria-induced immune response is of importance.  
 
Health-related Feed Additives 
Importance 
 Antibiotics are utilized in a variety of ways in animal agriculture and the possible 
implication this has on human health has become a major concern in the past decade for both 
producers and consumers. The Food and Drug Administration’s Center for Veterinary Medicine 
approves the use of antibiotics in food animals for disease treatment, control, prevention, and 
nutritional efficiency (Institute, 2018). It is the latter of the four uses that has caused 
consternation amongst the food animal industry and has led to the implementation of new 
regulations on the use of antibiotics in food animal production. 
 The use of antibiotics to promote nutritional efficiency was first reported in 1946 when 
Moore and colleagues published evidence on the growth promoting effects of subtherapuetic 
levels (i.e., less than amount required) of sulfasuxidine, streptothricin, and streptomycin in the 
diets of chicks. Since then, antibiotics have been incorporated into the diets of livestock species 
as antibiotic growth promotors (AGPs) and are attributable to the economic effectiveness and 
sustainability of livestock production (Wierup, 2000). In an attempt to quantify the net effect of 
AGPs, Thomke & Elwinger (1998) proposed as much as a 3-4% increase in broiler growth 
performance may result from increased feed efficiency and weight gain when compared with 
broilers fed unsupplemented control diets. However, some of the antibiotics used at sub-
therapeutic levels in food animals as growth promotors are identical to the ones utilized in the 
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human health field, begging the question of whether antibiotic resistance in humans begins with 
animal agriculture (Cosby et al., 2015; Endtz et al., 1990; Gadde et al., 2017). Evidence of the 
transmission of resistance from animal to human was first observed when identical clones of E. 
coli isolates were present in fecal samples from both broilers and broiler farmers (van den 
Bogaard et al., 2001). Although evidence exists, the correlation between antimicrobial resistance 
in food animals and humans has never been clearly defined, leading to an ongoing discussion 
amongst scientists, government officials, and the public. 
Because of this, World Health Organization met in 1997 to determine whether the use of 
AGPs in animal agriculture had any impact on the escalation of antimicrobial resistance in 
humans (World Health Organization, 1997). Shortly thereafter, small groups of antibiotics being 
used as growth promotors in the Europe Union (EU) were banned, inevitably leading to their 
complete demise in January 2006, when AGP sale and marketing was prohibited entirely in the 
EU (Regulation No. 1831/2003) (European Commission, 2003).  
Following suit of the EU, the U.S. Food and Drug Administration took their first official 
regulatory step in December, 2013, by publishing Guidance for Industry #213, a non-binding 
recommendation that strongly encouraged animal drug sponsors to stop marketing antibiotics as 
growth promotors and that the remaining use of AGPs be brought under veterinarian supervision 
by December, 2016 (US Food and Drug Administration, 2013). Drugs that were once over-the-
counter and incorporated into the diets of food animals soon transitioned to requiring a veterinary 
feed directive as of January 1, 2017. Some of these drugs include aureomycin, penicillin, 
erythromycin, and sulfaquinoxaline (Administration, 2016). These changes essentially make it 
more difficult for a producer to incorporate AGPs into the diets of their animals, although they 
have not been officially banned in the U.S..  
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 The poultry industry has relied heavily on the use of anticoccidial drugs when trying to 
alleviate the detrimental effects of coccidiosis. The use of an anticoccidial drug was first 
documented by Levine (1939) when he investigated the drug sulfanilamide and its ability to 
inhibit coccidiosis. Anticoccidial drugs are a kind of antibiotic that specifically counteract 
Eimeria and are quantified based on their efficacy of coccidiostatic activity (Reid et al., 1969). 
Inevitably, after their discovery, a shift in the susceptibility of an anticoccidial drug to mitigate 
coccidiosis was noted and an acquisition of resistance to all anticoccidial drugs has been 
demonstrated globally (Abbas et al., 2011).  
In the past, bacterial resistance to antimicrobial drugs was met with the development of 
novel classes of drugs or chemical alterations to existing drugs to circumvent antimicrobial drug 
resistance. Presently, there is no assurance that the development of novel drugs and chemical 
alterations will be able to keep up with the ability of bacterial pathogens to develop drug 
resistance (Gold & Moellering, 1996). Because of this, and the growing pressure from regulatory 
bodies and public concern, there exists a strong impetus to develop alternatives for antibiotics 
and anticoccidial drugs that do not allow for significant detriments in broiler growth 
performance. 
Alternatives to antibiotics and anticoccidial drugs: Phytogenic compounds 
 The Animal Health Institute in 1998 estimated that the U.S. would require an additional 
452 million chickens, 23 million more cattle, and 12 million more pigs in order to maintain the 
present level of animal production without the use of growth promoting antibiotics (Hughes & 
Heritage, 2004). In addition, the National Chicken Council reported that chicken consumption 
per capita has increased nearly every year since the mid 1960’s, and Americans, in particular, 
purchase more chicken than any other meat source (Council, 2017). These two powerful 
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statistics demonstrate the pressure the poultry industry is under to keep up with the ever-growing 
demands of consumers for poultry, while shifting to an unavoidable antibiotic-free era. Due to an 
increase in resistance to anticoccidial drugs and also because of increased public concern about 
the increase in antibiotic resistance to microorganisms, evidence of nutritional alternatives, 
specifically phytogenic compounds, to combat coccidiosis is becoming more relevant. 
Numerous alternatives have been introduced to the poultry industry that strive to maintain 
optimal growth performance while promoting overall bird health. Some of the class of 
alternatives include probiotics, prebiotics, synbiotics, organic acids, enzymes, hyper immune egg 
yolk antibodies, clays, bacteriophages, and lastly, phytogenic compounds (Gadde et al., 2017). 
Feed International conducted a world-wide nutrition and feed survey to investigate how poultry 
farmers are formulating their poultry diets for antibiotic-free production. Thirty-five percent of 
respondents reported using phytogenic compounds/essential oils as alternatives for AGPs in their 
feed formulations (Roembke, 2016).  
Phytogenic compounds are a group of non-antibiotic feed additives of plant origin that 
are incorporated into animal feed and are available in the form of solids, extracts, or essential oils 
(Yitbarek, 2015). When compared with inorganic chemicals and synthetic antibiotics, it has been 
suggested that phytogenic compounds are natural and less toxic additives that possess 
antimicrobial and antifungal properties (Yitbarek, 2015). The efficacy of a phytogenic compound 
varies greatly depending on plant parts used (e.g., seed, root, flowers, buds, and bark), 
geographical origin of the source plant, and harvest season (Muthusamy & Sankar, 2015). Other 
potential factors can affect the overall bioactivity of a phytogenic compound such as extraction 
method (Handa et al. , 2008), housing conditions (Pirgozliev et al., 2014), and synergistic effects 
when combining compounds (Yang et al., 2015). Classes of phytogenic compounds include 
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alkaloids, glycosides, flavonoids, phenolics, saponins, tannins, terpenes, anthraquinones, 
essential oils, and steroids (Doughari, 2012).  
Plants that possess an array of phytogenic compounds have been utilized as potential 
alternatives to anticoccidial drugs in order to ameliorate the effects of coccidiosis in chickens. 
Coccidiosis was alleviated in chickens when extracts from Sophora flavescnes, Oregeno, and 
Astragulus membranaceus were used (Applegate, 2009). Dried Artemesia annua, a plant that 
contains phytogenic compounds like flavonoids and saponins (Kumar Ashok & Upadhyaya, 
2013), when incorporated into the diet at a 5% inclusion rate over a three week period, reduced 
E. tenella-induced cecal lesions (Allen et al., 1997). An extract derived from the herb U. 
macrocarpa increased survival rate and decreased lesion scores in Eimeria challenged birds 
(Youn & Noh, 2001). Saponins are one class of phytogenic compounds that are of plant origin 
and may prove to be beneficial in terms of mitigating coccidiosis in chickens. 
Saponins 
 Dietary intervention as an alternative to antibiotics and anticoccidial drugs is gaining 
interest, specifically plant extracts that contain powerful secondary metabolites, or 
phytochemicals. One such phytochemical, saponin, has been suggested as an alternative strategy 
for controlling effects of coccidiosis (Galli et al., 2018). Saponins are naturally occurring steroids 
or surface-active triterpenoid glycosides whose name is derived from the ability of a saponin to 
form stable, soap-like foams in aqueous solutions, thus making them strong surfactants (Francis 
et al., 2002). A majority of saponins are produced by plants, but they can also originate from 
lower marine organisms (Riguera, 1996). Desert plants are abundant in saponins; the two most 
common commercial sources are the Mexican desert derived Yucca schidigera and the Chile 
derived Quillaja saponaria (Cheeke, 2000). Saponins are also found in wild plants and have 
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been detected in soybeans, beans, peas, horse chestnut, oats, and ginseng (Francis et al., 2002). 
Structurally, a saponin consists of a lipophilic nucleus, either steroid or triterpenoid in structure 
depending on plant origin, with one or more water-soluble carbohydrate side chains (Cheeke, 
2000). The classification of a saponin is dependent on nucleus structure, thus classifying the 
Yucca schidigera derived saponins as steroidal and the Quillaja saponaria derived saponins as 
triterpenoidal (Francis et al., 2002). Isolation of saponins has proven rather difficult due to their 
particular polar, amphiphilic nature that allows them to occur as complex mixtures with other 
similar surrounding secondary metabolites and the absence of a chromophore imposes further 
hindrance (Marston et al., 2000). Bark and wood from Quillaja saponaria must be subjected to 
boiling, condensation, and evaporation techniques, whereas the trunk of Yucca schidigera must 
be subjected to maceration and evaporation techniques for isolation of saponins (Cheeke, 2000). 
Although isolation of saponins is difficult, recent technologic advancements and modernization 
of techniques have allowed for nearly complete isolation of saponins via chromatographic 
techniques, like high-performance liquid chromatography, within reasonable quantities for an 
overall quality control test of a product (Marston et al., 2000).  
 The unique chemical structure of a saponin enables it to have different biological effects 
on animal health. Saponins extracted from Yucca schidigera have proven to be especially 
beneficial for controlling ammonia and odor emissions in animal rearing facilities. This is 
especially pertinent to poultry rearing facilities because chickens excrete uric acid, a compound 
that can be converted to ammonia, as the principal nitrogenous constituent of their excreta due to 
their lack of complete urea cycling (Stevens, 1996). Birds fed a diet containing 120 mg of Yucca 
schidigera/kg of diet significantly decreased the ammonia concentration measured in broiler 
houses (Çabuk et al., 2004). The exact mode of action by which saponins reduce ammonia 
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emissions is poorly understood, but Makkar et al. (1999) demonstrated that Yucca schidigera 
was more effective than Quillaja saponaria in binding to and therefore reducing concentrations 
of ammonia. Duffy and colleagues (2001) suggested that both the non-butanol-extractable 
fraction (i.e., mainly non-saponin carbohydrates) and the butanol-extractable fraction (i.e., 
saponins) of Yucca extract are attributable for nitrogen-metabolism, indicating that the active 
constituents are present in both fractions and working collectively, rather than one or the other.  
In addition to their odor controlling capability, saponins also possess antiprotozoal and 
antibacterial activities due to their ability to disrupt cellular membranes (Cheeke et al., 2006). 
Saponins exhibit lytic action on protozoal cell membranes, but the exact molecular mechanisms 
for doing so are poorly understood. Probable modes of action for saponins and their ability to 
modify membrane function include the formation of insoluble saponin-cholesterol complexes 
with protozoal cells, formation of phospholipid breakdown products, and alterations in the 
organization of sarcolemma membrane phospholipids, all of which can modify protozoal 
membrane structure and function leading to eventual cell lysis (Francis et al., 2002). Protozoal 
diseases that undergo a large majority of their life cycle in the gastrointestinal tract act in 
response to the antiprotozoal activity of saponins (Cheeke et al., 2006). The target membrane and 
orientation of a saponin can also affect the efficacy of its ability to disrupt the membrane 
interaction (Francis et al., 2002). Steroidal saponins, like the ones found in Yucca schidigera, 
have been shown to exhibit antibacterial and antiprotozoal effects in ruminal microorganisms 
(Wallace et al., 1994). A powdered preparation of Yucca schidigera was effective in killing 
tropozoites from Giardiaintestinalis, a common protozoal intestinal pathogen similar in nature to 
that of Eimeria (McAllister et al., 2001). Addition of Yucca extract at 350 ppm enhanced a 
protective effect against coccidiosis for its ability to decrease the presence of oocysts in excreta 
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(Galli et al., 2018). Guar meal, a high protein by-product of galactomannan gum, is saponin-rich 
(5-13% by weight of dry matter) and when included at a dietary concentration of 5%, reduced 
the number of oocysts per gram in excreta when broilers were challenged with E. tenella (Hassan 
et al., 2008). These results demonstrate the antiprotozoal activity of saponins and their ability to 
inhibit the growth of coccidiosis as seen by a decrease in oocyst shedding following an Eimeria 
challenge.  
Studies indicate that saponins may also improve nutrient digestibility. Johnson et al. 
(1986) established in vitro that saponins, both triterpenoid and steroidal, readily increased 
permeability of the mucosal small intestine cells. This was established by showing inhibition of 
active transport through a carrier-mediated galactose transporter, which in turn impeded uptake 
of nutrients that the small intestine was otherwise impermeable by simultaneously increasing the 
uptake of passively transported L-isomer glucose. An increase in nutrient absorption has the 
potential to improve growth performance through increases in feed efficiency. When 
incorporated in broiler diets at 100 mg/kg, Yucca schidgera extract increased average daily gain 
and feed efficiency in broilers during the finisher phase (d 29 to d 42) (Sun et al., 2017). Sahoo et 
al. (2015) also reported an improvement in the feed conversion ratio of broilers when 
supplemented with 125 mg/kg of diet of a Yucca supplement, in addition to a decrease in 
agonistic behavior like pecking and avoidance of other birds. In contrast, saponins have the 
ability to interact with protein in the diet and decrease digestibility, dependent on protein source. 
When Quillaja-derived saponins were fed to gerbils in conjunction with two different protein 
sources, casein and isolated soy protein, serum cholesterol concentrations were decreased by 
32% in casein-fed gerbils. These results suggest that Quillaja-derived saponins can modify blood 
lipids in the presence of casein by altering digestion of proteins, resulting in a slower release of 
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protein when compared to ingestion of these protein sources alone (Potter et al., 1993). 
Therefore, protein source should be taken into consideration when formulating a diet that 
incorporates saponins. If used to their potential, saponins may prove to be a natural alternative to 
antibiotics and anticoccidial drugs due to their antiprotozoal activity and ability to enhance 
nutrient absorption and growth in broilers.  
Due to limitations of current strategies to control coccidiosis, and because there are 
significant economic losses due to decreased body weight gain and feed efficiency in affected 
animals, identifying immunomodulating compounds to limit coccidiosis and improve 
performance in poultry is of great value. Collectively, the use of dietary saponins may serve as 
an effective strategy in mitigating the resulting inflammatory response following exposure to 
Eimeria in broilers.  
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CHAPTER 3: EFFECTS OF YUCCA-DERIVED SAPONIN SUPPLEMENTATION 
DURING A MIXED EIMERIA CHALLENGE IN BROILERS 
Abstract  
 
An experiment was conducted to determine if dietary Yucca-derived saponin 
supplementation could ameliorate the immune and growth responses of broilers during a mixed 
coccidian challenge. A total of 576 two-day-old male Ross 308 broiler chicks were housed in 
galvanized starter batteries and randomly assigned to 1 of 4 dietary treatment groups (12 
replicate cages of 7 birds). Dietary treatments were corn-soybean meal-based and included: 1) 
control diet + sham-inoculated (Ucon), 2) control diet + Eimeria oocyst challenge (Icon), 3) 
control diet with 250 mg/kg Yucca-derived saponin product + Eimeria oocyst challenge 
(ISap250), and 4) control diet with 500 mg/kg of Yucca-derived saponin product + Eimeria 
oocyst challenge (ISap500). On study d 14, birds were orally inoculated with 1.5 ml of tap water 
containing E. acervulina, E. maxima, and E. tenella (100,000, 40,000, and 30,000 oocysts/dose, 
respectively), or sham-inoculated with 1.5 ml of tap water. Eimeria-challenged birds exhibited a 
reduction in growth compared with uninfected birds (P < 0.001); however, there were no 
detectable differences due to dietary treatment among Eimeria-challenged groups. Mucosal 
thickness in the jejunum was increased in all infected groups (P < 0.05), but there were no 
differences among infected groups, however, saponin supplementation included at 250 mg/kg 
was not significantly different from the uninfected birds. Lymphocytes as a percentage of total 
white blood cells were increased (P < 0.05) in all Eimeria-challenged groups at 7 days post 
inoculation compared with uninfected birds, but birds supplemented at 250 mg/kg were not 
different from uninfected birds. Saponin supplementation in conjunction with an Eimeria 
challenge had no effect on cecal-derived T-cell profiles (P > 0.05). Cecal and duodenal IFN-γ 
expression increased with infection when compared with sham-inoculated birds. Cecal and 
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duodenal IL-1β expression increased due to infection and ISap250 and ISap500 treatments 
ameliorated IL-1β expression to levels not different from sham-inoculated birds (P < 0.05). 
Interleukin-12 β expression increased in the duodenum of cocci-infected birds compared to 
uninfected birds (P < 0.05), but dietary treatments had no measureable effects. These results 
suggest that saponin supplementation may provide some immunomodulatory effects during a 
mixed coccidian challenge as evidenced by lymphocyte responses, changes in intestinal 
structure, and alterations in cecal and duodenal inflammatory cytokine mRNA expression. 
 
Introduction 
Avian coccidiosis is a major parasitic disease affecting the poultry industry resulting from 
intestinal parasitic infection by the protozoan species of genus Eimeria and is said to be found 
wherever chickens are raised (Williams, 1998). There are seven different species widely 
encountered within the poultry industry, but only E. acervulina, E. brunetti, E. maxima, E. 
necatrix, and E. tenella yield quantifiable gross lesions in varying spots along the gastrointestinal 
tract (GIT), the preferred site of habitation in broilers (Allen & Fetterer, 2002). Coccidiosis is 
manifested by a destruction of the intestinal epithelia and has the ability to initiate an immune 
response from the host, thereby leading to increased maintenance costs, decreased absorption of 
nutrients, and ultimately diminished animal growth (Preston-Mafham & Sykes, 1970). 
Coccidiosis is one of the most economically significant diseases for poultry producers worldwide 
due to its cost of control measures, prevalence in poultry rearing facilities, and subsequent 
consequences on growth performance parameters (Williams, 1999). 
 Because of the pathogenicity of Eimeria species, reproductive life cycle, and current 
management practices within the poultry industry, a variety of control measures have been 
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developed to mitigate the detrimental effects of coccidiosis. The poultry industry has 
successfully relied on the use of prophylactic chemotherapeutic agents, or anti-coccidial drugs, 
which can directly affect parasite metabolism, osmotic balance, and ion transport in the GIT of 
birds to make the intestinal environment less habitable (Chapman, 2001, 2014; McDougald, 
1998). However, due to an increase in resistance to anti-coccidial drugs (Abbas et al., 2011) and 
also because of increased public concern about the increase in antibiotic resistance 
microorganisms (Cosby et al., 2015), alternatives to combat coccidiosis in order to ameliorate the 
economic losses due to decreased growth performance in affected chickens has become of great 
importance. 
Numerous phytogenic compounds have been introduced to the poultry industry as 
alternatives that strive to maintain optimal growth performance while promoting overall bird 
health (Gadde et al., 2017). One such phytogenic compound, saponins, have been reported to 
improve nutrient digestibility (Johnson et al., 1986), growth performance (Sahoo et al., 2015; 
Sun et al., 2017), and odor control in broilers (Çabuk et al., 2004). Saponins are natural 
detergents that have the ability to bind to membrane cholesterol of protozoan cells leading to 
eventual cell lysis and cell death, giving rise to anti-protozoal properties as well (Francis et al., 
2002). Based on previous literature indicating that saponins have beneficial effects, the objective 
of the current study was to determine if dietary supplementation of Yucca-derived saponins could 
ameliorate the immune and growth responses of broilers during a mixed coccidian challenge. 
 
Materials and Methods 
All animal care and experimental procedures were approved by the University of Illinois 
Institutional Animal Care and Use Committee before initiation of the experiment. 
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Bird Husbandry  
Five hundred and seventy-six male Ross × Ross 308 broiler chicks were obtained 2 d 
post-hatch from a commercial hatchery and placed in thermostatically-controlled batteries with 
raised wire floors in an environmentally-controlled room with continuous lighting. Upon arrival, 
birds were weighed, wing-banded, and assigned randomly to 1 of 4 dietary treatment groups, and 
allotted to pens (99 cm x 34 cm) such that average initial group weights and weight distributions 
were similar across treatments. Each treatment was replicated with 12 battery cages (n=12) each 
containing a total of 12 chicks at study initiation. Birds were provided free access to water and 
experimental diets (Table 1) that met or exceeded requirements for this age of broilers (NRC, 
1994). All diets were corn-soybean meal based and saponin supplementation (Micro-Aid® Feed 
Grade Concentrate; DPI Global, Porterville, CA) was included on top of the formulation (i.e., no 
space reserved in the formulation) as having negligible nutritive contribution to the overall diet. 
The following diet names were assigned to the experimental treatment groups:1) control diet + 
sham-inoculated (Ucon), 2) control diet + Eimeria oocyst challenge (Icon), 3) control diet with 
250 mg/kg of Yucca-derived saponin product + Eimeria oocyst challenge (ISap250), and 4) 
control diet with 500 mg/kg of Yucca-derived saponin product + Eimeria oocyst challenge 
(ISap500). Bird and feeder weights were recorded on the day of arrival, and then bi-weekly until 
study completion for calculation of body weight gain, feed intake, and feed efficiency to assess 
growth performance. At 16 d of age (d 14 of study), birds were weighed and the number of birds 
in each pen was adjusted to leave 7 birds per cage for the inoculation period. The 5 birds that 
were chosen to be removed were chosen such that when the 12 birds were placed in order of 
descending weight, the lightest 3 birds and heaviest 2 birds were culled. One bird was selected 
from each replicate cage on days 14, 21, and 28 of study (0, 7, and 14 days post-inoculation 
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(DPI)) and humanely euthanized for sample collection. The bird chosen for sample collection 
was based on weight such that when the birds were placed in descending order by weight, the 
bird closest to the average weight was chosen. Mortality during the study was less than 8% and 
was unrelated to treatment. Feed efficiency and feed intake were corrected to include weight gain 
of birds that died during the trial. 
Proximate Analysis of Experimental Diets  
 A sample of each experimental diet was used to analyze the nutrient composition of each 
individual diet (Table 2). Diets were analyzed for dry matter (DM) (method 934.01, AOAC 
International, 2002) and organic matter, which was done by first determining percent ash 
(method 942.05, AOAC International, 2002) and subtracting that from 100. Crude fat was 
determined by using the traditional Soxhlet extraction method with diethyl ether (method 920.39, 
AOAC International, 2006) and crude protein was determined by measuring nitrogen using a 
Leco analyzer (TruMac N, Leco Corp., St. Joseph, MI) standardized with EDTA (method 
990.03, AOAC International, 2006). Fiber analysis was determined by quantifying neutral 
detergent fiber and acid detergent fiber (method 2002.04, 973.18, AOAC International, 2002). 
Gross energy was determined using an adiabatic bomb calorimeter (Parr 6200, Parr Instruments, 
Moline, IL) standardized with benzoic acid. 
Eimeria Challenge  
Three strains of Eimeria, acervulina, maxima, tenella, were originally obtained from the 
University of Arkansas, Fayetteville, AR (courtesy of Dr. David Chapman) and were maintained 
in our laboratory by periodic passage (every 3 to 5 months) through broiler chickens. Oocysts 
were isolated from excreta and allowed to sporulate in 2.5% K2Cr2O7 at 28°C under forced 
aeration before storage at 4°C. Immediately before inoculation, sporulated oocysts were washed 
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free of K2Cr2O7 and diluted with distilled water to desired concentrations. At 16 d of age (0 
DPI), birds were challenged orally with 1.5 ml of tap water containing a mixture of E. acervulina 
(100,000 oocysts per dose), E. maxima (40,000 oocysts per dose), and E. tenella (30,000 oocysts 
per dose) or sham-inoculated (unchallenged) with 1.5 ml of tap water orally. These inclusion 
levels of Eimeria oocysts were derived from a recent study conducted in the lab and served to 
induce a mild-to-moderate reduction in growth performance of the birds. Birds infected with 
Eimeria were housed in batteries separated from the unchallenged birds. After the coccidial 
challenge, all personnel were required to conduct procedures on unchallenged birds before 
working on the Eimeria-infected birds to maintain biosecurity. Infection was confirmed by 
oocyst counts of excreta samples collected from pans beneath each pen on days 7 and 14 DPI for 
oocysts per gram outcomes. On the day of collection, samples were homogenized, and Eimeria 
oocysts were enriched then diluted based on their infection status, and counted using a McMaster 
counting chamber (Chalex Corporation, Ketchum, ID).  
Histopathological Morphometries & Lesion Scoring 
At 14 DPI, independent sub-samples from the jejunum and the duodenum were collected 
from one bird in each pen. The bird chosen for sample collection was based on weight such that 
when the birds were placed in descending order by weight, the bird closest to the average weight 
was chosen. Immediately following sample collection of fresh tissue from the bird, the 
duodenum and jejunum were immersed in 10% neutral buffered formalin and sent to an external 
histopathology laboratory for morphometrical analysis by a board-certified histopathologist 
(Veterinary Diagnostic Pathology, LLC, Fort Valley, VA). Sections of tissue (2 mm) were 
trimmed from the submitted tissue, placed into cassettes, and prepared for paraffin-embedded 5 
μm sections stained with hematoxylin and eosin (H&E). In order to ensure uniformity of 
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assessment, intestinal sections were kept intact in circular form. The duodenal sub-sample was 
also utilized for histopathological lesion scoring. A lesion scoring system developed for 
commercial poultry production gut assessment and inclusive to the findings of the project were 
used and lesions were semi-quantitatively scored for severity as 0, normal; 1, minimal severity; 
2, mild severity; 3, moderate; 4, marked; and 5, severe (APPENDIX).  
Differential Blood Cell Counts 
On 0, 7 and 14 DPI, one bird per pen was euthanized for collection of blood. The bird 
chosen for sample collection was based on weight such that when the birds were placed in 
descending order by weight, the bird closest to the average weight was chosen. Chicks were bled 
by cardiac puncture into evacuated tubes. A sample (~2 mL) of blood was submitted to the 
Veterinary Clinical Pathology Laboratory at the University of Illinois at Urbana-Champaign for 
measuring the total and differential blood cell counts at each time-point. 
Immunophenotyping 
Immunophenotyping of T-cell populations was conducted at 14 DPI using cecal tonsils 
(same bird used for differential blood cell counts). Cecal tonsils were collected and placed on ice 
until cell isolation was conducted. Briefly, mononuclear cells were isolated by crushing cecal 
tonsils through a cell strainer to allow cells to flow through and onto a density gradient 
(Histopaque; Sigma Aldrich, St. Louis, MO). Following centrifugation (1800 rpm × 20 min.; 
25°C; without a brake), mononuclear cells were separated, washed twice, and their 
concentrations were adjusted to 1 × 106 total cells. Cells were then surface-stained using the 
following antibody clones and conjugated fluorochromes: anti-CD3-FITC (clone: CT-3), anti-
CD4-PE (clone: CT-4), and anti-CD8α-APC (clone: CT-8) (Southern Biotech, Birmingham, 
AL). Once stained with theses surface markers, cells were washed three times and then 
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permanently fixed with 2% paraformaldehyde for 10 minutes at room temperature, and then 
washed an additional three times. Cells were left at 4° C overnight until analysis the following 
day. The relative percentage of different phenotypes of T cells (i.e., single stain for CD4 or CD8 
double positive T-cells) were determined using multi-color flow cytometry (BD LSR II Flow 
cytometry analyzer, Roy J. Carver Biotechnology Center, University of Illinois, Urbana-
Champaign, IL). 
Inflammatory Cytokine mRNA Expression  
Samples of cecal tonsils and duodenum were collected at 7 DPI for quantitative real-time 
polymerase chain reaction (PCR) in order to quantify relative gene expression of the pro-
inflammatory cytokines interferon-γ (IFN-γ), interleukin -1β (IL-1β), and interleukin-12β (IL-
12β). Samples were collected and immediately submerged in RNAlater stabilization solution 
(AM7020; Thermo Fisher Scientific Inc., Waltham, MA) and placed at room temperature 
overnight to allow its penetration into the tissues. Subsequently, 24-h following collection, 
samples + RNAlater were then moved to -80°C freezer pending further analysis. Upon analysis, 
cecal tonsil and duodenum tissue samples, (50 to 100 mg), were placed into a 2 mL 
microcentrifuge tube along with 1 mL of TRIzol reagent (Invitrogen, Carlsbad, CA) and a 5 mm 
steel bead. Samples were homogenized through tissue disruption for 2 minutes at 30 Hz 
(TissueLyser II, Qiagen, Valencia, CA) and RNA was extracted following manufacturer 
instructions. Extracted RNA was quantified using a spectrophotometer, with samples having a 
260:280 absorbance ratio of 1.8 or higher (NanoDrop ND-1000, Nano-Drop Technologies, 
Wilmington, DE). The extracted RNA was transcribed to complementary DNA (cDNA) using a 
high capacity cDNA Reverse Transcription kit (Thermo Fisher Scientific Inc., Waltham, MA). 
The samples were placed in a thermocycler (Bio-Rad, Hercules, CA) set to 25°C for 10 minutes, 
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37°C for 120 minutes, 85°C for 5 minutes, and then cooled at 4°C and held there until the cDNA 
samples were removed and stored at -20°C until plating. The TaqMan Gene Expression Assay 
(Thermo Fisher Scientific Inc., Waltham, MA) was used to perform quantitative real-time PCR 
to quantify relative gene expression of pro-inflammatory cytokines IFN-γ (NM_205149.1), IL-1β 
(NM_204524.1), and IL-12β (NM_213571.1). Amplification was achieved by PCR for both 
target (IFN-γ, IL-1β, IL-12β) and reference (GAP-DH, NM_204305.1; Hong et al. 2006) chicken 
genes. Sample cDNA was amplified using TaqMan (Thermo Fisher Scientific Inc., Waltham, 
MA) oligonucleotide probes containing 5ʹ fluorescent reporter dye (6-FAM) and 3ʹ non-
fluorescent quencher dye, and fluorescence was determined using a QuantStudio™ 7 Flex Real-
Time PCR System (Applied Biosystems, Foster City, CA). Gene expression was normalized 
through parallel amplification of endogenous GAPDH for each sample. Relative gene expression 
was calculated using the comparative threshold cycle (Ct) method (Livak & Schmittgen, 2001) 
and results are expressed as fold-change relative to sham-inoculated broilers fed the control diet. 
Statistical Analyses 
The experimental design was a completely randomized block design. Data were subjected 
to an analyses of variance using a MIXED procedure of SAS (version 9.4). A 1-way ANOVA 
was used to determine whether the model was significant, and when appropriate, means 
separation was conducted. Least-square means and the standard error of the mean estimates were 
derived from this 1-way ANOVA. Replicate pen served as the experimental unit for all 
outcomes, and significance was accepted with a P-value of less than 0.05.  
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Results 
Growth Performance 
All growth performance data are shown in Table 3. Oocysts per gram for treatment Ucon 
yielded positive results, but because of values near that of zero, a high dilution factor, and 
possible cross contamination of just excreta pans, not the birds themselves, from previously-
conducted studies, these positive values were viewed as negligible and an anomaly when 
compared with the other treatment groups and were excluded from the final dataset. Birds 
challenged orally with the Eimeria mixture exhibited a reduction in growth compared with birds 
not challenged with the Eimeria mixture. During the first 14 days of the study, birds in treatment 
ISap500 had increased feed intake compared with birds in all other treatments. Birds assigned to 
ISap500 also had a decrease in gain:feed during the first 14 days of study. 
Histopathological Morphometrics  
For the two parameters crypt depth and the villus height to crypt depth ratio (villus:crypt 
ratio), a difference between Eimeria-infected and non-infected groups was observed (Table 4). 
However, when comparing within infected groups, there were no statistical differences noted for 
crypt depth, though there was a reduction in the villus:crypt ratio for birds assigned to the 
ISap250 treatment when compared with other dietary treatments. A treatment effect was noted 
for mucosal thickness in the jejunum, where ISap250 and UCon yielded similar results, with a 
numeric reduction in mucosal thickness in birds fed ISap250 compared with the other Eimeria-
infected groups. 
Histopathological Lesion Scoring 
From lesion scoring data alone (Table 5), the birds challenged orally with the Eimeria 
mixture exhibited an increase in the following outcomes when compared with sham-inoculated 
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birds: incidence of lamina propria lymphocytes and plasma cells, intraepithelial leukocytes, 
enteritis index, and total enteritis index. However, there were no detectable differences due to 
dietary treatment within the Eimeria-infected groups.  
Differential Blood Cell Counts 
At 0 DPI, total protein for ICon and ISap250 were elevated compared to Ucon and 
ISap500, which did not differ from each other (Table 6). At 7 DPI, hematocrit and heterophils 
showed differences only between uninfected and Eimeria-infected birds, and not between 
treatments within infected groups. Band heterophils and monocytes/azurophilic granules were 
elevated for ISap250 and ISap500 when compared with other treatment groups and basophils 
measurements of ISap250 were significantly higher when in comparison to all other treatment 
groups. Lymphocytes were elevated in all Eimeria-infected treatment groups and did not differ 
from one another when compared with UCon, but ISap250 was not significantly different than 
the Ucon birds. At 14 DPI, there was no detectable difference in differential blood cell counts 
amongst the dietary treatment groups. Taken together, uninfected birds outperformed birds that 
were Eimeria-infected; however, birds fed an inclusion rate of 250 mg/kg of diet of saponin 
supplementation did express similar lymphocyte percentages to that of the uninfected birds at 7 
DPI. 
Immunophenotyping 
All immunophenotyping data are shown in Table 7. There was no significant difference 
between immunophenotyping of different subsets of T-cells derived from mononuclear cells 
from chicken cecal tonsils fed different levels of saponin supplementation during a coccidial 
oocyst challenge. 
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Gene expression 
Gene expression data are shown in Table 8 and are reported as a fold-change relative to 
the sham-inoculated birds fed the control diet. In the cecal tonsils, IFN-γ mRNA expression 
increased in Icon, ISap250, and ISap500 when compared to Ucon (P < 0.001). Expression of 
cecal mRNA IL-1β was increased only for the treatment Icon, but not for the ISap250 and 
ISap500 treatments (P < 0.01). Treatments ISap250 and ISap500 significantly decreased 
expression of IL-1β in comparison to treatment Icon. Duodenal IL-1β mRNA expression 
increased with infection, but remained unchanged with saponin supplementation at both the 250 
and 500 mg/kg inclusion rates. Duodenal IL-12β mRNA expression was increased with infection, 
however, birds fed ISap250 were not different from the Ucon birds (P < 0.05). Duodenal IFN-γ 
mRNA expression was also increased with infection (P < 0.001).  
 
Discussion 
Based on previous literature indicating that saponins have beneficial effects during 
parasitic infections, the objective of the current study was to determine if dietary 
supplementation of saponins via an extract from Yucca schidigera could ameliorate the immune 
and growth responses of broilers during a mixed coccidian challenge. We observed that saponin 
supplementation during a mixed coccidian challenge had no beneficial effects on growth 
performance, however, it may influence the immune response to Eimeria infection as evidenced 
by lymphocyte responses, changes in intestinal structure, and alterations in cecal and duodenal 
inflammatory cytokine mRNA expressions.  
Growth performance responses to saponin supplementation appear to be highly variable. 
Studies by Johnston et al. (1980) and Su et al. (2016) both report saponin supplementation via an 
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extract from Yucca schidigera serves as an effective growth promoter in broilers, while 
Sariozkan et al. (2015) reported Yucca extract had no significant influence on growth 
performance of broilers. Interestingly, Balog and collegues (1994) demonstrated a significant 
decrease in body weights with Yucca feeding. These studies measured performance in 
unchallenged broilers. When saponin supplementation was used in conjunction with an Eimeria 
challenge, Alfaro et al. (2007) recorded broilers had higher BWG, however, this study also used 
a commercial coccidiosis vaccination at the initiation of the study, suggesting that improvements 
in BWG may have been due to a synergistic effect between the supplementation and coccidiosis 
vaccine. Herein, we report that birds challenged orally with the Eimeria mixture exhibited a 
reduction in overall growth compared with birds not challenged with the Eimeria mixture. From 
these results, we concluded that sham-inoculated birds outperformed Eimeria-infected birds, but 
there were no detectable differences due to dietary treatment among Eimeria-infected groups. A 
possible explanation for no detectable differences amongst dietary treatments in growth 
performance may be due to the reduction in bio-efficacy of saponins when used during an 
immune challenge. Recently, antibiotic treatment was shown to alter microbiome-independent 
changes in host metabolites during infection, which in turn inhibited the antibiotic’s efficacy 
(Yang et al., 2017). As a possible alternative to antibiotics, saponins bio-efficacy could have 
been dampened due to infection with Eimeria, thus warranting no outwardly improvements in 
growth performance amongst dietary treatments.  
 Evidence of a successful Eimeria challenge was made possible through quantification of 
oocysts in excreta collected from birds. Birds challenged with Eimeria were shedding oocysts up 
to 622,695 oocysts/g of excreta at d 21 of study, but there was no treatment effect of saponin 
supplementation noted among Eimeria-inoculated treatment groups. This finding is contrary to 
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previous studies in which guar meal, a high protein by-product of galactomannan gum rich in 
saponins, reduced the number of oocysts per gram in excreta when broilers were challenged with 
E. tenella (Hassan et al., 2008). Histopathological lesion scoring of the duodenum further 
solidified evidence of a successful coccidian challenge due to birds being challenged showing 
increased total enteritis indexes (representation of inflammation and repair) in comparison to the 
control birds. Nonetheless, much like our growth performance parameters demonstrated, there 
were no detectable differences due to dietary treatment within the Eimeria-infected groups and 
sham-inoculated birds showed a trend toward a reduction in lesion scoring. It should also be 
noted that lesions identified in the duodenum broadly represent those common to commercial 
poultry production and were of generally minimal to moderate overall severity as reported by the 
histopathologist.  
Despite the inability for saponin supplementation to improve growth performance, 
diminish oocyst shedding, and alleviate coccidian induced lesions, our results show they modify 
morphological parameters of the jejunum 14 days following Eimeria infection. The 
multifunctional intestinal mucosal layer serves as a barrier between harmful pathogens and the 
underlying epithelial cells and when damaged, can result in inflammation, uncontrolled immune 
responses, and unbalanced organic homeostasis (Kitessa et al., 2014). It is crucial to maintain the 
integrity of the mucosal barrier in order to promote the overall adequacy of the GIT mucus layer 
which aids in protection from external environment, lubrication for gut epithelium, and nutrient 
transport (Montagne et al., 2004). Our study showed treatment effects for mucosal thickness in 
the jejunum with a numeric reduction in mucosal thickness in birds supplemented with saponins 
at 250 mg/kg of diet and no differences compared with the sham-inoculated groups, but there 
was no difference when comparing among infected groups. Saponin supplementation may 
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promote regeneration and reconstitution of the intestinal mucosal layer back to normal levels as 
evidenced by ISap250 birds not being significantly different than the unchallenged birds. This is 
important because an entire turnover of the mucosa could take up to 96 hours, which is equal to 
about 10% of the lifetime of a market-ready broiler (Gottardo et al., 2016). If a dietary 
intervention like saponin supplementation can diminish the time it takes for an immune-
challenged bird to return to homeostatic levels, it may prove beneficial to overall bird health 
during a mixed Eimeria challenge as evidenced by alterations in intestinal structure.  
 Acquired immunity to an Eimeria infection in broilers has already been demonstrated to 
be almost entirely driven by cell-mediation, which is characterized by antigen specific and non-
specific activation to stimulate diverse cell populations including lymphocytes (Allen & Fetterer, 
2002; Lillehoj & Trout, 1996). Although reactive lymphocytes can be detected in small numbers 
in healthy birds, an increase in lymphocytes is often viewed following exposure to infectious 
diseases and is an indicator that antigenic stimulation is occurring (Mitchell & Johns, 2008). Our 
results show an increase in total lymphocytes in all cocci-infected birds 7 DPI when compared to 
the un-infected birds, suggesting evidence of antigenic stimulation and development of 
immunological memory. Lymphocyte-mediated immunological memory is imperative to a bird’s 
livelihood following continual exposure to a reoccurring pathogen, resulting in reduced 
nutritional costs overtime as the bird is able to recognize the same pathogen with higher 
efficiency in the future (Klasing & Leshchinsky, 1999; Schat et al., 2013). Although imperative, 
initial development of immunological memory is complex, has nutritional expense, and even 
when not in use, has high maintenance costs (Klasing & Leshchinsky, 1999). It is crucial to find 
the balance between inducing an immune response in order to generate acquired immunity 
without exerting unwarranted damage to the host. Cocci-infected birds did have elevated 
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lymphocytes levels 7 DPI and did not differ from one another, yet birds supplemented at 250 
mg/kg of diet expressed similar lymphocyte percentages to that of the sham-inoculated birds. 
These findings suggest that saponin supplementation may possess some measureable 
immunomodulatory effects when analyzing lymphocyte responses and may curtail some of the 
undue costs an Eimeria-induced immune response has on a bird.  
 Although evidence of cell-mediation being the driving force behind generating protective 
immunity to Eimeria is well documented (Rose & Hesketh, 1979), we were unable to show 
differences in subsets of T-cell populations derived from mononuclear cells of chicken cecal 
tonsils via immunophenotyping. A possible explanation for this finding could be the timeframe 
in which T-cell populations were isolated from the cecal tonsils. Vervelde and colleagues (1996) 
showed an increase in CD4+ cells just two days after inoculation with E. tenella, whereas we 
quantified T-cell populations fourteen days post inoculation with Eimeria. Peaks in CD4+ T-cell 
populations were seen at three and eleven and CD8+ at four days post inoculation with E. 
maxima (Rothwell et al., 1995). Our quantification of T-cell populations could have been outside 
the window of an acquired immune response mounted by cell-mediation following an Eimeria 
challenge. Total lymphocyte percentages quantified from the blood fourteen days post 
inoculation in our study also showed no difference between the cocci-infected and uninfected 
birds, possibly indicating that antigenic stimulation and lymphocyte-mediated immunological 
memory were longer occurring. An alternative could also be that saponins may not exhibit their 
effects on cell-mediated pathways in non-mammalian species. Saponins have been used in non-
living adjuvants to produce a more robust immune response to generate protective immunity to 
an antigen, but in non-mammalian species this response is not as pronounced (Francis et al., 
2002). 
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 Expression of inflammatory genes, including IL-1β, in cecal tonsils and duodenal tissues  
of broilers at 7 DPI differed due to dietary saponin supplementation. While IL-1β elicits systemic 
metabolic, behavioral, and cellular changes that are crucial in initiating an immune response, this 
cytokine also has the ability to induce sickness-like behavior in animals resulting in retardation 
of growth comparable in strength to administration of lipopolysaccharide (Dantzer et al., 1993; 
Klasing & Leshchinsky, 1999). Expression of IL-1β following immune stimulation is 
unavoidable, but suppressing the amount expressed in a timely fashion in order to mitigate 
reductions in growth often associated with an immune response may prove to be beneficial, thus 
modifying the way in which a bird copes with coccidiosis. Our results suggest that saponins may 
possess some measureable immunomodulatory-anti-inflammatory-like properties. However, anti-
inflammatory polyphenolics like resveratrol and yuccaol C isolated from Yucca schidigera 
extract have been shown to inhibit NFκB activation, suggesting that the nature of our saponin 
supplementation derived from Yucca schidigera may account for the suppression in IL-1β, rather 
than saponin supplementation alone (Cheeke et al., 2006; Marzocco et al., 2004). As for IFN-γ 
production, our findings corroborate with previous reports of increased gene expression of 
intestinal IFN-γ due to Eimeria infection in chickens, although the timing and magnitude of 
response have varied considerably in the literature (Hong et al., 2006; Laurent et al., 2001; 
Rochell et al., 2016; Yun et al., 2000). Interferon-γ is another key pro-inflammatory cytokine 
that has been shown to exert direct inhibitory effects against Eimeria (Lillehoj & Choi, 1998), so 
it was of no surprise when our results showed an increase in IFN-γ 7 DPI in the cecal tonsils and 
duodenum. Because IL-12β can activate NK cells, which are important in protecting the host 
from pathogens and have ability to induce cell lysis and secrete IFN-γ, the significant increase in 
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expression of IL-12β in the duodenum is probably directly related to the increase in IFN-γ 
production (Murphy & Weaver, 2016). 
 In conclusion, these results suggest that saponin supplementation may influence the 
immune response of birds challenged with mixed coccidian oocysts. Eimeria-challenged birds 
exhibited a reduction in growth compared with uninfected birds, but there was no detectable 
differences due to saponin supplementation within Eimeria-challenged groups. Lymphocyte 
counts were increased in all Eimeria-challenged groups at 7 DPI compared with uninfected birds, 
but birds given saponin supplementation at 250 mg/kg were not significantly different from 
uninfected birds. Mucosal thickness in the jejunum was increased in all infected groups and there 
was no difference between infected groups; however, saponin supplementation included at 250 
mg/kg was not significantly different when compared to uninfected birds. Expression of IL-1β in 
the cecal tonsils and duodenum was increased following infection, but saponin supplementation 
at 250 and 500 mg/kg of diet reduced the expression of IL-1β to that of an unchallenged bird. 
These results suggest that saponin supplementation may possess some measurable 
immunomodulatory effects during infection as evidenced by lymphocyte responses, changes in 
intestinal structure, and alterations in cecal and duodenal inflammatory cytokine mRNA 
expressions. Collectively, the use of dietary saponins may serve as an effective strategy in 
mitigating the resulting inflammatory response following exposure to Eimeria in broilers. 
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Tables 
 
Table 1. Ingredient composition of the experimental basal diet1,2 
Ingredient, g/kg  Concentration, g/kg 
  Corn 444.5 
  Soybean meal 420.0 
  Soy Oil 90.0 
  Salt 4.0 
  Limestone 14.0 
  Dicalcium Phosphate 20.0 
  Vitamin Premix3 2.0 
  Mineral Premix4 1.5 
  DL-Methionine 2.0 
  Choline chloride 2.0 
Calculated composition  
  Protein,  g/kg 230.1 
  ME, kcal/kg 3301 
  Ca, g/kg 11.0 
  Total P, g/kg 7.5 
  nPP, g/kg 5.0 
  Ca:tP 1.5 
  Ca:nPP 2.2 
Total AA, g/kg  
   Arg  16.3 
   His  6.4 
   Ile   10.1 
   Leu  20.1 
   Lys   13.8 
   Met  5.6 
   Met + Cys 9.4 
   Phe 11.6 
   Phe + Tyr 20.9 
   Thr 9.1 
   Trp 3.4 
   Val 11.1 
1Abbreviations: nPP = non-phytate phosphorus; tP = total phosphorus; ME = metabolizable energy; DM = dry 
matter. 
2The following diet names have been assigned to a respective experimental treatment group: Ucon: control diet + 
sham-inoculated; Icon: control diet + Eimeria oocyst challenge; ISap250: 250 mg/kg of fed saponin 
supplementation in diet + Eimeria oocyst challenge; ISap500: 500 mg/kg of fed saponin supplementation in diet + 
Eimeria oocyst challenge. Saponin supplementation (Micro-Aid® Feed Grade Concentrate; DPI Global, Porterville, 
CA) was included in ISap250 at 250 mg/kg and ISap500 at 500 mg/kg on top of the diet as having negligible 
nutritive contribution to the overall diet. 
3Provided per kilogram of complete diet: retinyl acetate, 4,400 IU; cholecalciferol, 25 μg; dl-α-tocopheryl acetate, 
11 IU; vitamin B12, 0.01 mg; riboflavin, 4.41 mg; d-Ca-pantothenate, 10 mg; niacin, 22 mg; and menadione sodium 
bisulfite complex, 2.33 mg. 
4Provided per kilogram of complete diet: Mn, 75 mg from MnO; Fe, 75 mg from FeSO4 ·7H2O; Zn, 75 mg from 
ZnO; Cu, 5 mg from CuSO4 ·5H2O; I, 0.75 mg from ethylene diamine dihydroiodid; and Se, 0.1 mg from Na2SeO3. 
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Table 2. Proximate analysis of experimental treatment diets1 
 Dietary Treatment 
Item Ucon Icon ISap250 ISap500 
Dry matter, % 88.08 88.00 87.91 87.90 
Organic matter, % of DM 92.09 92.14 92.35 91.85 
Crude fat, % of DM 11.07 10.39 11.25 11.27 
Crude protein, % of DM  26.32 27.18 26.25 24.12 
Neutral detergent fiber, % of DM  15.60 16.24 16.33 12.48 
Acid detergent fiber, % of DM  3.26 3.70 3.21 3.96 
Gross energy, Kcal/kg of DM  4,870 4,852 4,908 4,909 
1Abbreviations: DM, dry matter. The following diet names have been assigned to a respective experimental 
treatment group: Ucon: control diet + sham-inoculated; Icon: control diet + Eimeria oocyst challenge; ISap250: 
250 mg/kg of fed saponin supplementation in diet + Eimeria oocyst challenge; ISap500: 500 mg/kg of fed 
saponin supplementation in diet + Eimeria oocyst challenge. 
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Table 3. Growth performance and oocyst shedding for broilers fed different levels of saponin 
supplementation and exposed to an Eimeria oocyst challenge1 
 Uninfected  Cocci-infected  Pooled 
SEM 
Model  
P-value  Ucon  Icon ISap250 ISap500  
Body weight, g/bird         
d 14 391  386 393 391  9.7 0.80 
d 21 895a  723b 737b 737b  19.1 < 0.001 
d 28 1,495a  1,305b 1,314b 1,324b  30.1 < 0.001 
Body weight gain, g/bird         
d 1-14 357  352 359 357  9.1 0.79 
d 14-28 1,091a  903b 906b 929b  22.8 < 0.001 
d 1-28 1,460a  1,271b 1,280b 1,290b  29.6 < 0.001 
Feed intake, g/bird         
d 1-14 407b  411b 413b 433a  9.4 0.046 
d 14-28 1,384a  1,256b 1,274b 1,282b  26.7 < 0.001 
d 1-28 1,491a  1,391b 1,403b 1,447ab  26.0 0.008 
Gain:feed, g/kg         
d 1-14 875a  857a 870a 825b  10.8 0.011 
d 14-28 789a  718b 711b 716b  8.4 < 0.001 
d 1-28 980a  902b 912b 892b  11.2 < 0.001 
Oocysts per gram2         
d 21 -  506,253 521,871 622,695  65,853.0 0.41 
d 28 -  13,648 18,294 17,233  3,879.4 0.62 
abMeans without a common superscript letter differ within a row (P < 0.05). 
1Values are least-square means initially derived from 12 replicate pens of 12 birds at 2-d post-hatch (mean initial weight 34 ± 
5 g). The following diet names have been assigned to a respective experimental treatment group: Ucon: control diet + sham-
inoculated; Icon: control diet + Eimeria oocyst challenge; ISap250: 250 mg/kg of fed saponin supplementation in diet + 
Eimeria oocyst challenge; ISap500: 500 mg/kg of fed saponin supplementation in diet + Eimeria oocyst challenge. 
2Oocysts per gram for Ucon treatment was near zero for d 21 and d 28. 
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Table 4. Histopathology of the duodenum and jejunum of broilers fed different levels of saponin 
supplementation fourteen days post Eimeria oocyst challenge1,2 
 Uninfected  Cocci-infected  Pooled 
SEM 
Model  
P-value Item                  Ucon3  Icon3 ISap2503 ISap5003  
Duodenum, µM         
    Villi height 2468  2316 2169 2386  90.4 0.12 
    Crypt depth 259.5b  315.8ab 363.3a 328.5a  21.2 0.012 
    Villus:crypt ratio 10.11a  7.63b 6.37c 7.58b  0.450 < 0.001 
    Mucosal 
thickness 
2727  2631 2533 2714  101 0.48 
Jejunum, µM         
    Villi height 1011  1327 1182 1250  81.1 0.054 
Crypt depth 182.5  229.2 201.8 219.4  16.7 0.18 
Villus:crypt ratio 6.01  6.27 6.11 6.16  0.383 0.97 
     Mucosal 
thickness 
1194b  1556a 1384ab 1469a  91.0 0.042 
abcMeans without a common superscript letter differ within a row (P < 0.05). 
 1The following values were derived at a magnification level of 40x. 
 2Values are least-square means initially derived from 1 bird per pen, 12 replicate pens per treatment. 
3The following diet names have been assigned to a respective experimental treatment group: Ucon: control diet + sham-inoculated; 
Icon: control diet + Eimeria oocyst challenge; ISap250: 250 mg/kg of fed saponin supplementation in diet + Eimeria oocyst challenge; 
ISap500: 500 mg/kg of fed saponin supplementation in diet + Eimeria oocyst challenge. 
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Table 5. Histopathological lesion scoring of the duodenum of broilers fed different levels of saponin supplementation fourteen 
days post coccidial oocyst infection1,2 
Item                                  
Uninfected  Cocci-infected Pooled 
SEM 
Model  
P-value Ucon  Icon ISap250 ISap500 
Coccidia 0  0 0 0 -3 -3 
Villus shortening 0  0 0 0 -3 -3 
Crypt hyperplasia 0  0 0 0 -3 -3 
Lamina propria lymphocytes and plasma 
cells 
0.292a  1.083b 1.500b 1.417b 0.264 0.005 
Bacteria4 1.000  0.500 0.250 0.250 0.266       0.16 
Cystic crypts 0  0.167 0 0.250 0.092       0.11 
Intraepithelial leukocytes 0.956a  1.583b 2.250c 1.750bc 0.267 0.002 
Other5 0  0.250 0.091 0.250 0.108       0.27 
Coccidia index6 0  0 0 0 -3 -3 
Enteritis index7 2.236a  3.583b 4.360b 4.167b 0.495 0.003 
Total enteritis index8 2.232a  3.667b 4.539b 4.167b 0.494 0.002 
abcMeans without common superscript letter do differ within a row (P < 0.05). 
1The duodenum was examined microscopically for lesions and parasites. A lesion panel developed for commercial poultry production gut assessment and 
inclusive to the findings of the project was used and lesions were semi-quantitatively scored for severity as 0, normal; 1, minimal severity; 2, mild 
severity; 3, moderate; 4, marked; and 5, severe.  
 2Values are least-square means initially derived from 12 replicates per treatment. The following diet names have been assigned to a respective 
experimental treatment group: Ucon: control diet + sham-inoculated; Icon: control diet + Eimeria oocyst challenge; ISap250: 250 mg/kg of fed saponin 
supplementation in diet + Eimeria oocyst challenge; ISap500: 500 mg/kg of fed saponin supplementation in diet + Eimeria oocyst challenge. 
 
 
3Absense of statistical analysis due to infinite likelihood. 
4Bacteria on tips or sides of villi and dysbacteriosis. 
5Includes increased goblet cells and/or mucus, attenuated enterocytes, misshapen villus tips, heterophils in the lamina propria, or contracted villi. 
6Calculated by summing the coccidian scores for duodenum only, meaning coccidian index is equal to coccidian lesion score. 
7Calculated by summing all lesion scores.  
8Calculated by subtracting the coccidia index from the enteritis index, representing inflammation and repair. 
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Table 6.  Effects of saponin supplementation fed at different levels during a Eimeria oocyst challenge on total and 
differential blood cell counts in broilers1 
 Uninfected  Cocci-infected  Pooled 
SEM 
Model  
P-value Item Ucon2  Icon2 ISap2502 ISap5002  
Hematocrit, %         
0 DPI 28.8  30.7 29.0 28.9  1.22 0.67 
7 DPI 30.7a  23.0b 24.3b 24.9b  1.96 0.027 
14 DPI 31.1  31.1 30.4 31.6  0.877 0.83 
Total protein, g/dL         
0 DPI 2.93b  3.27a 3.28a 2.92b  0.106 0.037 
7 DPI 3.10  3.40 3.32 3.23  0.167   0.52 
14 DPI 3.05  3.33 3.30 3.32  0.148   0.50 
WBC count, ×103/µL         
0 DPI 16.1  17.3 15.5 12.6  2.89    0.70 
7 DPI 12.7  11.6 14.8 15.6  2.16    0.55 
14 DPI 23.3  23.1 24.5 22.1  3.39    0.97 
Heterophils, % of WBC         
0 DPI 18.0  19.3 21.8 19.0  4.76    0.95 
7 DPI 44.8a  27.2b 22.0b 18.0b  3.61 < 0.001 
14 DPI 45.7  39.8 40.0 38.2  4.11    0.58 
Band heterophils, % of WBC         
0 DPI 0.167  0.167 0 0.333  0.158    0.54 
7 DPI 0b  0b 0.833a 0.400ab  0.206 0.021 
14 DPI 0.800  0 0.167 0.667  0.229    0.06 
abMeans without a common superscript letter differ within a row (P < 0.05). 
1Values are least-square means initially derived from 1 bird per pen, 6 replicate pens per treatment. Abbreviations: DPI = days post-inoculation; 
WBC = white blood cell (i.e., leukocytes). 
2The following diet names have been assigned to a respective experimental treatment group: Ucon: control diet + sham-inoculated; Icon: control diet 
+ Eimeria oocyst challenge; ISap250: 250 mg/kg of fed saponin supplementation in diet + Eimeria oocyst challenge; ISap500: 500 mg/kg of fed 
saponin supplementation in diet + Eimeria oocyst challenge. 
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Table 6.  (cont.) 
 Uninfected  Cocci-infected  Pooled 
SEM 
Model  
P-value Item Ucon2  Icon2 ISap2502 ISap5002  
Lymphocytes, % of WBC         
0 DPI 73.3  73.3 69.8 74.3  5.28    0.94 
7 DPI 41.8b  60.8a 51.0ab 57.3a  4.49 0.014 
14 DPI 39.7  49.2 49.0 50.2  4.27    0.22 
Eosinophils, % of WBC         
0 DPI 2.33  1.67 0.83 1.17  0.744 0.53 
7 DPI 5.33  5.00 5.83 7.17  1.91 0.86 
14 DPI 1.17  1.50 0.667 1.67  0.508 0.54 
Basophils, % of WBC         
0 DPI 4.00  3.17 3.20 2.20  0.687 0.33 
7 DPI 7.83b  5.83b 12.7a 8.50b  1.46 0.010 
14 DPI 7.00  4.67 5.83 4.00  1.10 0.22 
Monocytes/azurophilic granules, % of WBC         
0 DPI 2.17  2.33 2.00 1.17  0.447 0.23 
7 DPI 0.17b  1.17b 7.67a 7.50a  1.40 0.001 
14 DPI 5.17  4.83 4.33 2.83  1.08 0.46 
abMeans without a common superscript letter differ within a row (P < 0.05). 
1Values are least-square means initially derived from 1 bird per pen, 6 replicate pens per treatment. Abbreviations: DPI = days post-inoculation; 
WBC = white blood cell (i.e., leukocytes). 
2The following diet names have been assigned to a respective experimental treatment group: Ucon: control diet + sham-inoculated; Icon: control diet 
+ Eimeria oocyst challenge; ISap250: 250 mg/kg of fed saponin supplementation in diet + Eimeria oocyst challenge; ISap500: 500 mg/kg of fed 
saponin supplementation in diet + Eimeria oocyst challenge. 
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Table 7.  Effects of saponin supplementation fed at different levels during a coccidial oocyst challenge on 
immunophenotyping of different subsets of T-cells derived from mononuclear cells from chicken cecal tonsils1 
 Uninfected  Cocci-infected  Pooled 
SEM 
Model  
P-value Item Ucon  lcon ISap250 ISap500  
Total T cells, % of isolated cells 
(CD3+)2 
36.59  31.72 34.16 38.71  2.35 0.22 
Helper T cells, % of total T cells  
(CD3+CD4+)3 
38.09  41.49 48.72 43.79  3.13 0.14 
Cytotoxic T cells, % of total T cells 
(CD3+CD8+)3 
41.06  36.94 32.51 38.21  3.10 0.21 
Memory T cells, % of total T cells 
(CD3+CD4+CD8+)3 
2.08  4.21 3.51 5.40  1.41 0.36 
1Values represent least square means of 1 bird per pen, 6 replicate pens per treatment group with collection of cecal tonsils occurring at 14 days post-
inoculation. The following diet names have been assigned to a respective experimental treatment group: Ucon: control diet + sham-inoculated; Icon: 
control diet + Eimeria oocyst challenge; ISap250: 250 mg/kg of fed saponin supplementation in diet + Eimeria oocyst challenge; ISap500: 500 mg/kg 
of fed saponin supplementation in diet + Eimeria oocyst challenge. 
2Percent of total lymphocytes that are positive for cell-surface marker CD3. 
3Percent of CD3-positive lymphocytes that are also positive for cell-surface markers CD4, CD8, or CD4/CD8. 
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Table 8. Gene expression of the cecal tonsils and duodenum of broilers fed different levels of saponin supplementation seven 
days post coccidial oocyst infection1,2 
Item                        
Uninfected  Cocci-infected  Pooled 
SEM 
Model  
P-value Ucon  Icon ISap250 ISap500  
Cecal tonsils         
  IL-1β 1.00a  2.07b 1.48a 1.26a  0.196 0.008 
  IL-12β 1.00  1.67 1.46 1.65  0.265 0.22 
  IFN-γ 1.00a  9.87c 5.12b 5.50b  1.009 < 0.001 
Duodenum          
  IL-1β 1.00a  1.52b 1.00a 1.17ab  0.157 0.039 
  IL-12β 1.00a  2.13b  1.66ab 2.32b  0.221 0.003 
  IFN-γ 1.00a  6.10b 5.31b 4.64b  0.958 < 0.001 
abcMeans without a common superscript letter differ within a row (P < 0.05). 
1Values are least-square means initially derived from 1 bird per pen, 6 replicates pens per treatment. Abbreviations:; IL-1β=interleukin 1 beta; IL-
12β=interleukin 12 beta; IFN-γ=interferon gamma. The following diet names have been assigned to a respective experimental treatment group: Ucon: 
control diet + sham-inoculated; Icon: control diet + Eimeria oocyst challenge; ISap250: 250 mg/kg of fed saponin supplementation in diet + Eimeria 
oocyst challenge; ISap500: 500 mg/kg of fed saponin supplementation in diet + Eimeria oocyst challenge. 
2Values are reported as fold-change. 
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CHAPTER 4: GENERAL CONCLUSIONS 
 
The overall focus of this study was to evaluate if dietary supplementation of Yucca-
derived saponins could ameliorate the immune and growth responses of broilers during a mixed 
coccidian challenge. We concluded that while sham-inoculated birds outperformed Eimeria-
infected birds, there were no detectable differences due to dietary treatment of saponin 
supplementation within the Eimeria-infected groups. Saponin supplementation modified the way 
in which lymphocytes responded to infection. Total lymphocytes as a percentage of white blood 
cells increased in all Eimeria-challenged groups at 7 DPI when compared with uninfected birds, 
but birds fed 250 mg/kg of diet of saponin supplementation were not significantly different than 
uninfected birds. An inclusion rate of 250 mg/kg of diet of saponin supplementation also altered 
intestinal structure of the jejunum. Mucosal thickness in the jejunum was increased in all 
Eimeria-infected groups and there was no difference between infected groups; however, saponin 
supplementation included at 250 mg/kg was not significantly different from the uninfected birds. 
Inflammatory cytokine gene expression within the duodenum and cecal tonsils was impacted by 
saponin supplementation. In the cecal tonsils and duodenum, IFN-γ expression was increased 
with infection compared to unchallenged birds. Expression of cecal IL-1β was increased only in 
the infected birds while saponin supplementation reduced the expression to match that of the 
uninfected birds. Contrarily, duodenal IL-1β expression increased with infection, but remained 
unchanged with saponin supplementation.  
These results revealed that saponin supplementation may influence the immune response 
during infection with Eimeria due to its effects on lymphocyte responses, changes in intestinal 
structure, and alterations in inflammatory cytokine gene expression. Due to limitations of current 
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strategies to control coccidiosis, and because there are significant economic losses due to 
decreased BW gain and feed efficiency in affected animals, identifying compounds to limit 
coccidiosis and improve performance in poultry is of great value. Saponin supplementation 
offers a natural alternative to prophylactic chemotherapeutic agents in addition to staying in the 
realm of governmental regulations while assuaging to the growing public for microorganismal 
resistance. Collectively, the use of dietary Yucca-derived saponins may serve as an effective 
alternative strategy in ameliorating the resulting inflammatory response following exposure to 
Eimeria in broilers. Future research should be directed towards discovering the exact 
mechanistic pathway for which saponins are able to exhibit their effects during a mixed 
coccidian challenge.  
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APPENDIX: MICROSCOPIC LESION SCORING  
 
Standard Operating Procedure Form for Histopathological Lesion Scoring  
Prepared by: Dr. Fred Hoerr, Veterinary Diagnostic Pathology, LLC 
 
0-5 Scoring 12/17/16 
 
Coccidia 
 
Eimeria acervulina 
0, absent; 
1, 1 cluster per section entire gut section; 
2, 2 clusters; 
3, 3 clusters; 
4, 4 clusters; 
5 , 5+ clusters. 
 
Eimeria maxima and E. mivati 
0, no coccidia observed; 
1, 0-20 coccidia/entire gut section; 
2, up to 50; 
3, up to 75; 
4, up to 100; 
5, >100 coccidia/section 
 
Eimeria tenella 
0, absent; 
1, small cluster of infection; 
2, scattered small clusters of coccidia; 
3 scattered large clusters of coccidia; 
4, large clusters of coccidia, some confluence; 
5, multiple confluence to diffuse infection 
 
Small Intestine Lesion Scoring 
Scoring was on a 0-5 scale with 0 being no lesions, 1 = rare or slight 2 = mild, 3 = moderate, 4 = 
marked, 5 = severe. Villus atrophy was scored and checked by see and sort method. 
 
Villus shortening 
0 - tallest in the set, 
1 = 20% loss in height, 
2 = 40% loss in height, 
3 = 60% loss in height, 
4 = 80% loss in height, 
5=80% or more 
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Crypt hyperplasia 
0 = none, 
1 = minimal 
2 = mild 
3 = moderate, 2X normal; 
4 = marked (3X normal) 
5= severe more than 3x normal 
 
GALT hyperplasia 
0 = no increased cell population in the lamina propria; 
1 = sparse population of LP with lymphocytes, plasma cells and small mononuclear cells with up 
to 2 small lymphoplasmacytic cluster; 
2 = multifocal to diffuse mild infiltrates with 3-5 or more small lymphocytic clusters; 
3 = confluent mild diffuse infiltrates of the LP involving crypts and villi; 
4 = moderate diffuse infiltrates in LP of crypts and villi; 
5 = marked, diffuse infiltrates in LP of crypts and villi. 
 
Cystic Crypts 
0 = none; 
1 = 1; 
2 = 2-3; 
3 = 4-6; 
4 = 7-10; 
5 = >10. 
 
Small intestine, other 
1(mild) or 2 points (moderate) for each for any of the following, to a maximum of 5: 
- Heterophils in the lamina propria 
- Increased numbers/prominence of goblet cells 
- Mucus streaming from the sides and tips of villi 
- Misshapen, flattened, irregular, or eroded or micro-ulcerated tips of villi 
- Contracted villi 
- Other 
 
Pancreas 
Extramedullary hematopoiesis/myelopoiesis or LC Pancreatic foci 
0 = none, 
1 = 1- 2 lymphoid foci or few to mild granulocytic infiltrates, 
2 = 3-5 small to medium or mild to moderate; 
3 = more than 6 to coalescing 
4 Confluent 
5 Confluent to diffuse 
Cecum 
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Eimeria tenella 
0, absent; 
1, small cluster of infection; 
2, scattered small clusters of coccidia; 
3, scattered large clusters of coccidia; 
4, large clusters of coccidia, some confluence; 
5, multiple confluence to diffuse infection 
 
Lamina propria lymphoid hyperplasia 
0 = no increased cell population in the lamina propria; 
1 = sparse population of LP with lymphocytes, plasma cells and small mononuclear cells with up 
to 2 small lymphoplasmacytic cluster; 
2 = multifocal to diffuse mild infiltrates with 3-5 or more small lymphocytic clusters; 
3 = confluent mild diffuse infiltrates of the LP involving crypts; 
4 = moderate diffuse infiltrates in LP of crypts; 
5 = marked, diffuse infiltrates in LP of crypts. 
 
Bacterial adherence to mucosa 
0 = non-adherence 
1 = to 20% of mucosa 
2 = to 40% 
3 = to 60% 
4 = to 80% 
5 > 80% 
 
Cecum, other 
 
1 (mild) or 2 points (moderate) for each for any of the following, to a maximum of 5: 
- Lamina propria apoptosis 
- Heterophil inflammation 
- Necrosis, increased apoptosis, or microulceration of dome epithelium 
- Cystic glands (crypts), 
- Increased intraepithelial leukocytes 
- Other 
 
